\n\n
Medication & Prescriptions

Desmopressin Has Stopped Working After Six Months: What Comes Next

6 min read

Desmopressin works well for many children—until it doesn’t. If your child has been taking it for around six months and the wet nights have started creeping back, you’re not alone, and you haven’t done anything wrong. Tachyphylaxis—the medical term for the body becoming less responsive to a medication over time—is a recognised phenomenon with desmopressin. It’s one of the more frustrating aspects of managing nocturnal enuresis long-term. This article explains what is likely happening, what the clinical options are, and how to move forward without starting from scratch.

## Why Desmopressin Can Stop Working Over Time

Desmopressin is a synthetic version of antidiuretic hormone (ADH), which signals the kidneys to reduce urine production overnight. It works by compensating for a deficit in natural ADH—not by training the bladder or changing anything structurally.

After several months of effective use, some children develop a partial tolerance. The exact mechanism isn’t fully understood, but leading theories include:

– Downregulation of renal receptors that respond to ADH
– Changes in the child’s physiology as they grow (body weight, kidney maturation)
– Seasonal fluid shifts—higher fluid intake in warmer months can overwhelm the medication’s effect
– Gradual natural improvement in the child’s own ADH production, paradoxically making the dosage less well-matched

It’s also worth checking the basics before assuming tolerance: has the dose been reviewed recently? Has the child’s weight increased significantly? Is the tablet being taken at the right time (typically 30–60 minutes before bed on an empty stomach or bladder)? These are easy variables to overlook.

## First Step: Go Back to the Prescriber

Before changing anything, book an appointment with a GP or paediatrician. This is not just procedural—it matters clinically. The prescriber may want to:

– **Review the current dose.** NICE guidance allows desmopressin up to 0.4mg (oral tablet) or 240mcg (melt formulation). If your child has been on a lower dose, there may be room to titrate upward.
– **Switch formulation.** Some children respond better to the melt (sublingual) form than the tablet, or vice versa. Absorption differences are real.
– **Consider a structured break.** A two-to-four-week planned pause from desmopressin can sometimes reset receptor sensitivity. This should only be done under supervision—abrupt unplanned discontinuation isn’t recommended.
– **Rule out secondary causes.** If wet nights have returned after a period of dryness, it’s worth checking for constipation, urinary tract infection, or new stressors—all of which can undermine medication effectiveness. [Sudden worsening of bedwetting](https://www.sleepsecurenights.com/bedwetting-has-suddenly-got-much-worse-overnight-when-to-worry-and-what-to-check/) always warrants a closer look.

If you feel your concerns aren’t being taken seriously, that’s a separate issue worth addressing directly. [There are practical steps you can take if the GP isn’t listening.](https://www.sleepsecurenights.com/the-gp-dismissed-our-bedwetting-concern-what-parents-can-do-when-they-are-not-heard/)

## Clinical Options When Desmopressin Alone Isn’t Enough

### Combination Therapy: Desmopressin Plus Alarm

The bedwetting alarm and desmopressin work through different mechanisms—and research supports combining them for children who haven’t achieved full dryness with either alone. The alarm targets arousal and bladder conditioning; desmopressin reduces urine volume. Used together, they can produce results that neither achieves alone.

NICE guidance (NG111) acknowledges combination therapy as appropriate when monotherapy is insufficient. If your child hasn’t yet tried an alarm alongside the medication, this is often the next clinical step.

Bear in mind that alarms require consistent use over 8–12 weeks and demand effort from the whole household. If you’ve already tried this route without success, see our guide on [what to do when alarm, desmopressin, and lifting have all been tried.](https://www.sleepsecurenights.com/we-have-tried-the-alarm-desmopressin-lifting-and-nothing-has-worked-next-steps/)

### Anticholinergic Medication

If there’s any suggestion of bladder overactivity—urgency, frequency, daytime accidents, or a small bladder capacity—a prescriber may consider adding an anticholinergic such as oxybutynin or solifenacin. These work on bladder muscle rather than urine volume, addressing a different part of the problem.

This combination is more common in specialist settings than in primary care, so a referral may be necessary.

### Tricyclic Antidepressants (Imipramine/Amitriptyline)

Occasionally used as a third-line option when first- and second-line treatments have failed, tricyclics have a long history in nocturnal enuresis management. They have a more complex side-effect profile than desmopressin and are generally avoided in children under seven. They are not commonly prescribed in the UK for this indication anymore, but remain an option in refractory cases—particularly in specialist paediatric settings.

### Referral to a Specialist Enuresis Clinic

If primary care has exhausted its options, a referral to a paediatric enuresis or continence clinic is appropriate. These clinics have access to urodynamic testing, specialist nursing support, and the full range of treatment options. If you’ve been managing this in primary care for months without resolution, requesting a referral is reasonable.

Children who have been through a clinic and discharged without achieving dryness face specific challenges—more information is available in our article about [what to do after clinic discharge without dryness.](https://www.sleepsecurenights.com/my-child-has-been-to-the-bedwetting-clinic-and-was-discharged-without-being-dry/)

## In the Meantime: Protecting Sleep

While working through the next steps, protecting everyone’s sleep is important. If the medication is no longer providing reliable cover, wet nights are likely to return, leading to laundry, disruption, and fatigue.

Reliable overnight containment isn’t a step backward. It’s sensible management while treatment is being adjusted. Options include pull-ups, higher-capacity briefs, bed pads, and waterproof mattress protectors—whatever reduces the overnight burden without distressing the child.

Some children who have been dry on desmopressin for months may find it psychologically harder to return to nighttime protection. How you introduce this conversation matters. The [guide on talking about bedwetting without shame](https://www.sleepsecurenights.com/how-to-talk-about-bedwetting-without-shame-or-embarrassment/) offers practical language to help.

## What Not to Do

– **Don’t simply increase the dose yourself.** Desmopressin has a ceiling, and exceeding recommended doses risks hyponatraemia (dangerously low sodium). Any dose change must be supervised by a healthcare professional.
– **Don’t abruptly stop the medication** without a plan—sudden cessation after months can cause a sharp return of symptoms, making the situation worse.
– **Don’t interpret reduced effectiveness as treatment failure for all time.** For many children, a planned break followed by a restart at a reviewed dose can restore responsiveness. This is a recognised clinical pattern, not a dead end.

## What Comes Next: A Summary

1. Book an appointment with the GP or paediatrician—do not adjust the medication yourself.
2. Ask specifically about dose review, formulation change, or a supervised treatment break.
3. Discuss combination therapy (alarm plus desmopressin) if not already tried.
4. Request a referral to a specialist enuresis clinic if primary care options are exhausted.
5. Implement practical overnight protection to reduce disruption while treatment is being adjusted.
6. Keep a brief wetting diary for two weeks before the appointment—record timing, volume, and patterns. This information is very helpful.

Desmopressin stopping after six months is a recognised clinical scenario, not an indication that your child is difficult to treat. The options above are evidence-supported and accessible through NHS pathways. The next step is a conversation with a prescriber who can review the full picture and decide on appropriate adjustments.